Washington Drug Letter: Free 30-day Trial

Free Trial FREE 30-DAY TRIAL

Washington Drug Letter (WDL) gives you concise coverage of the FDA’s and other regulators’ actions, congressional legislation and hearings, federal and state court decisions, and industry moves to influence government policies and procedures.

Each issue provides:

  • Insight into the implications of FDA and congressional actions related to drug safety;
  • First word of FDA enforcement actions on issues ranging from off-label promotion to improper manufacturing practices; and
  • Developments in the generics sector, DTC advertising and drug pricing, regulatory guidances on drug impurities, structured product labeling and IND applications

PLUS: in every issue, you get links to additional key documents that support WDL’s articles, such as FDA letters, guidances, warning letters and 483s, rules, full texts of proposed legislation, GAO reports and more. Other features include:

Weekly, 30-day electronic trial subscription